"Pre-metastatic niches" in breast cancer: Are they created by or prior to the tumour onset? "Flammer Syndrome" relevance to address the question

EPMA Journal

Volumn 8, Issue 2, 2017, Pages 141-157

  Bubnov, Rostyslav ^a,b   Polivka, Jiri ^c,d   Zubor, Pavol ^e,f   Konieczka, Katarzyna ^g   Golubnitschaja, Olga ^h  

^a Clinical Hospital Pheophania of State Affairs Department   (Ukraine)

^b ZABOLOTNY INSTITUTE OF MICROBIOLOGY AND VIROLOGY   (Ukraine)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Martinska Fakultna Nemocnica   (Slovakia)

^f University Hospital in Martin   (Slovakia)

^g UNIVERSITY OF BASEL   (Switzerland)

^h UNIVERSITY OF BONN   (Germany)

Author keywords

"Seed and Soil" theory; Breast cancer; Flammer syndrome; Liver; Metastatic disease; Patient stratification; Predictive preventive personalised medicine; Systemic hypoxia

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIGENETICS; FEMALE; FLAMMER SYNDROME; GENETIC PREDISPOSITION; HUMAN; HYPOTHESIS; HYPOXIA; METASTASIS; PATHOPHYSIOLOGY; PREMETASTATIC NICHE; PRIMARY TUMOR; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 85020717512     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-017-0092-8     Document Type: Article

References (36)

1. Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, et al. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. 2016;37(10):12941-57. doi: 10.1007/s13277-016-5168-x.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262.
3. Golubnitschaja O, Sridhar KC. Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis. 2016;33(8):743-55. doi: 10.1007/s10585-016-9816-8.
4. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004;22(17):3608-17.
5. Chang EL, Lo S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 2003;8(5):398-410.
6. Polivka J, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O. Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J. 2017; doi: 10.1007/s13167-017-0087-5.
7. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Winer EP, Freedman RA. Factors associated with early mortality among patients with de novo metastatic breast cancer: a population-based study. Oncologist. 2017; doi: 10.1634/theoncologist.2016-0369.
8. Wu X, Baig A, Kasymjanova G, Kafi K, Holcroft C, Mekouar H, et al. Pattern of local recurrence and distant metastasis in breast cancer by molecular subtype. Cureus. 2016;8(12):e924.
9. Chung IY, Lee JW, Lee JS, Park YR, Min YH, Lee Y, et al. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer. PLoS One. 2017;12(3):e0170311. doi: 10.1371/journal.pone.0170311.
10. Wang J, Wang J, Li Q, Zhang P, Yuan P, Ma F, et al. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts. Oncotarget. 2017; doi: 10.18632/oncotarget.15268.
11. Masuda T, Hayashi N, Iguchi T, Ito S, Eguchi H, Mimori K. Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol. 2016;10(3):408-17. doi: 10.1016/j.molonc.2016.01.010.
12. Suchorska WM, Lach MS. The role of exosomes in tumor progression and metastasis (review). Oncol Rep. 2016;35(3):1237-44. doi: 10.3892/or.2015.4507.
13. Høye AM, Erler JT. Structural ECM components in the premetastatic and metastatic niche. Am J Phys. 2016;310(11):C955-67. doi: 10.1152/ajpcell.00326.2015.
14. Schito L, Rey S, Tafani M, Zhang H, Wong CC-L, Russo A, et al. Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci U S A. 2012;109(40):E2707-16. doi: 10.1073/pnas.1214019109.
15. Semenza GL. The hypoxic tumor microenvironment: a driving force for breast cancer progression. Biochim Biophys Acta. 2016;1863(3):382-91. doi: 10.1016/j.bbamcr.2015.05.036.
16. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst. 1999;91(13):1113-24.
17. Fidler IJ, Yano S, Zhang R-D, Fujimaki T, Bucana CD. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 2002;3(1):53-7.
18. Rutkowski MR, Svoronos N, Perales-Puchalt A, Conejo-Garcia JR. The tumor macroenvironment: cancer-promoting networks beyond tumor beds. Adv Cancer Res. 2015;128:235-62. doi: 10.1016/bs.acr.2015.04.011.
19. Chin AR, Wang SE. Cancer tills the premetastatic field: mechanistic basis and clinical implications. Clin Cancer Res. 2016;22(15):3725-33. doi: 10.1158/1078-0432.CCR-16-0028.
20. Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J. 2017;8(1):17-22. doi: 10.1007/s13167-017-0086-6.
21. Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM. Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monatsbl Augenheilkd. 2014;231(4):344-7.
22. Konieczka K, Fränkl S. Primäre vaskuläre Dysregulation und Glaukom (Primary vascular dysregulation and glaucoma). Z prakt Augenheilkd. 2013;34:207-15.
23. Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). EPMA J. 2016;7:13. doi: 10.1186/s13167-016-0062-6.
24. Konieczka K, Koch S, Schoetzau A, Todorova MG. Increased prevalence of Flammer syndrome in patients with retinitis pigmentosa. Klin Monatsbl Augenheilkd. 2016;233(4):448-52. doi: 10.1055/s-0041-111802.
25. Konieczka K, Todorova MG, Chackathayil TN, Henrich PB. Cilioretinal artery occlusion in a young patient with flammer syndrome and increased retinal venous pressure. Klin Monatsbl Augenheilkd. 2015;232(4):576-8.
26. Konieczka K, Flammer J, Sternbuch J, Binggeli T, Fraenkl S. Leber's hereditary optic neuropathy, normal tension glaucoma, and Flammer syndrome: long term follow-up of a patient. Klin Monatsbl Augenheilkd. 2017; doi: 10.1055/s-0042-119564.
27. Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263-72. doi: 10.1007/s13167-010-0032-3.
28. Zubor P, Gondova A, Polivka Jr J, Kasajova P, Konieczka K, Danko J, et al. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017; doi: 10.1007/s13167-017-0089-3.
29. Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, et al. Flammer syndrome. EPMA J. 2014;5(1):11. doi: 10.1186/1878-5085-5-11.
30. On the approval and implementation of medical and technological documents for standardisation of medical care of breast cancer [Internet]. Governmental Directive Number 396; Available from: http://www.moz.gov.ua/docfiles/dn_20150630_0396_ukp_dod.pdf.
31. Golubnitschaja O, Yeghiazaryan K, Liu R, Mönkemann H, Leppert D, Schild H, et al. Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients. J Glaucoma. 2004;13(1):66-72.
32. Golubnitschaja O, Yeghiazaryan K, Stricker H, Trog D, Schild HH, Berliner L. Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer. 2016;16(1):357. doi: 10.1186/s12885-016-2382-2.
33. Mohan P, Antonelou M, Dadzie O, Dubrey S. Headache in a young woman: leptomeningeal metastasis as the first presentation of underlying breast malignancy. BMJ Case Rep. 2015; doi: 10.1136/bcr-2014-207643.
34. Manders P, Sweep FCGJ, Tjan-Heijnen VCG, Geurts-Moespot A, van Tienoven DTH, Foekens JA, et al. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clin Cancer Res. 2003;9(17):6363-70.
35. Pal SK, Vuong W, Zhang W, Deng J, Liu X, Carmichael C, et al. Clinical and translational assessment of VEGFR1 as a mediator of the premetastatic niche in high-risk localized prostate cancer. Mol Cancer Ther. 2015;14(12):2896-900. doi: 10.1158/1535-7163.MCT-15-0367.
36. Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J. 2017;8(1):23-33. doi: 10.1007/s13167-017-0081-y.